Nicox S.A. Return on Equity

Nicox S.A. (COX.PA) currently reports a ROE of -561.14%. That is below the Healthcare sector average of -75.84%. Use the charts on this page to explore Nicox S.A.'s ROE history and peer comparisons.

Nicox S.A.'s ROE of -561.14% is lower than the Healthcare sector average of -75.84%. That is roughly 639.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Nicox S.A.'s current -561.14% should be judged against Healthcare norms (sector average: -75.84%) and against COX.PA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -561.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Nicox S.A., and consider following COX.PA for alerts when major investors trade the stock.

Nicox S.A. is classified in the Healthcare sector. On ROE, it currently shows -561.14% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COX.PA with unrelated industries.